A New Systemic Disease Mouse Model for Glioblastoma Capable of Single-Tumour-Cell Detection.

ABSTRACT:

Background

Glioblastoma is characterised by extensive infiltration into the brain parenchyma, leading to inevitable tumor recurrence and therapeutic failure. Future treatments will need to target the specific biology of tumour recurrence, but our current understanding of the underlying mechanisms is limited. Significantly, there is a lack of available methods and models that are tailored to the examination of tumour recurrence.

Methods

NOD-SCID mice were orthotopically implanted with luciferase-labelled donor U87MG or MU20 glioblastoma cells. Four days later, an unlabelled recipient tumor was implanted on the contralateral side. The mice were euthanised at a humane end-point and tissue and blood samples were collected for ex vivo analyses.

Results

The ex vivo analyses

SUBMITTER: Ware TMB 

PROVIDER: S-EPMC10814551 | biostudies-literature | 2024 Jan

REPOSITORIES: biostudies-literature